PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Neurosci. Author manuscript; available in PMC 2010 May 11.
Published in final edited form as:
PMCID: PMC2818669
NIHMSID: NIHMS163955

Hyperdopaminergic Tone Erodes Prefrontal LTP via a D2 Receptor-operated Protein Phosphatase Gate

Abstract

Dopamine (DA) plays crucial roles in the cognitive functioning of the prefrontal cortex (PFC), which, to a large degree, depends on lasting neural traces formed in prefrontal networks. The establishment of these permanent traces requires changes in cortical synaptic efficacy. DA, via the D1-class receptors, is thought to gate or facilitate synaptic plasticity in the PFC, with little role recognized for the D2-class receptors. Here we show that, when significantly elevated, DA erodes, rather than facilitates, the induction of long-term potentiation (LTP) in the PFC by acting at the far less abundant cortical D2-class receptors through a dominant coupling to the protein phosphatase 1 (PP1) activity in postsynaptic neurons. In mice with persistently elevated extracellular DA, resulting from inactivation of the DA transporter (DAT) gene, LTP in layer V PFC pyramidal neurons can not be established, regardless of induction protocols. Acute increase of dopaminergic transmission by DAT blockers or overstimulation of D2 receptors in normal mice have similar LTP shut-off effects. LTP in mutant mice can be rescued by a single in vivo administration of D2-class antagonists. Suppression of postsynaptic PP1 mimics and occludes the D2-mediated rescue of LTP in mutant mice, and prevents the acute erosion of LTP by D2 agonists in normal mice. Our studies reveal a mechanistically unique heterosynaptic PP1 gate that is constitutively driven by background DA to influence LTP induction. By blocking prefrontal synaptic plasticity, excessive DA may prevent storage of lasting memory traces in PFC networks and impair executive functions.

Keywords: Dopamine, prefrontal cortex, LTP, D2-class receptor, PP1, psychiatric disorder

Introduction

The PFC may store lasting memories and use this mnemonic information to guide behavior, thought, and emotion (Fuster, 1993; Goldman-Rakic, 1995; Seamans and Yang, 2004). Much of prefrontal functions, most notably working memory mediated by the dorsolateral PFC in primates (Goldman-Rakic, 1995) and the medial PFC (mPFC) in rodents (Seamans and Yang, 2004) depend on the mesocortical DA system. DA action is mediated by two classes of receptors. The D1-class receptors (D1 and D5) positively couple to the cAMP/PKA signaling that leads to phosphorylation of inhibitor 1 (I-1) and inhibition of PP1 (Greengard et al., 1999). The D2-class receptors, including D2, D3 and D4, negatively regulate this cAMP/PKA/I-1/PP1 cascade. In the PFC, dopaminergic and glutamatergic afferents converge onto the same dendritic spines of deep layer pyramidal neurons, forming “synaptic triads” (Goldman-Rakic et al., 1989; Carr and Sesack, 1996). Both classes of receptors are localized in distal spines in the PFC, with the D1 receptors being far more abundant than D2 receptors (Lidow et al., 1991; Gaspar et al., 1995). Through this heterosynaptic architecture, DA profoundly influences the transmission and plasticity of cortical glutamatergic systems.

The establishment of memory traces that underlie PFC functions are believed to depend on changes in synaptic strength, e.g. LTP, in cortical network (McClelland et al., 1995; Squire and Alvarez, 1995). As in most central synapses, prefrontal LTP requires activation of the NMDA receptor (NMDAR) (Hirsch and Crepel, 1991; Jay et al., 1995; Vickery et al., 1997; Zhao et al., 2005) and elevation of postsynaptic Ca2+ concentrations (Hirsch and Crepel, 1992). Limited studies have investigated the intracellular signaling mechanisms downstream to NMDAR activation and Ca2+ influx that trigger LTP in the PFC. Although it appears that calmodulin (CaM)-stimulated adenylyl cyclases (AC1 and AC8), PKA, and Ca2+/CaM-dependent protein kinase IV (CaMKIV) (Jay et al., 1998; Zhuo, 2008) mediate certain aspects of prefrontal LTP, the molecular and signaling details underlying the induction, expression, maintenance, and modulation of LTP in the PFC remain less explored (Otani et al., 2003; Zhuo, 2008) compared to other memory systems (Malenka and Bear, 2004; Kauer and Malenka, 2007).

DA is thought to facilitate LTP induction in the PFC. In both deep layer PFC synapses and hippocampal-PFC synapses, D1-class agonists facilitate, whereas antagonists impair, NMDAR-dependent LTP via cAMP-dependent mechanisms (Gurden et al., 2000; Huang et al., 2004). On the other hand, little contribution has been recognized for the D2 class in LTP induction (Gurden et al., 2000; Li et al., 2003; Huang et al., 2004; Lemon and Manahan-Vaughan, 2006). However, a low concentration of DA has been shown to convert an NMDAR-independent form of long-term depression (LTD) to LTP that requires both D1- and D2-class receptors (Matsuda et al., 2006), suggesting a “priming” role for background DA in PFC plasticity.

Here, we identify a prefrontal synaptic modification process that is sensitive to D2 dysregulation. Mice lacking the DA transporter (DAT), which controls DA transmission by reuptaking DA into presynaptic terminals, display a persistently elevated extracellular DA level and several other alterations in the DA system (Giros et al., 1996; Jones, et al., 1998). We show that LTP in the mPFC, considered to be homologous to the primate dorsolateral PFC (Kolb and Cioe, 2004), is absent in this hyperdopaminergia mouse model, revealing an unexpected eroding role for DA in LTP. This erosion can be mimicked in normal mice by acute elevation of DA levels using pharmacological agents, and is mediated by the far less abundant D2-class receptors and a downstream postsynaptic phosphatase gating mechanism. As elevated DA signaling is implicated in several neuropsychiatric disorders, such as schizophrenia, attention-deficit hyperactivity disorder (ADHD), and stress-induced prefrontal impairments (Seeman, 1987; Goldman-Rakic, 1995; Castellanos and Tannock, 2002; Arnsten, 2009), our studies are relevant to the understanding of the cellular and molecular basis of these disorders.

Materials and Methods

Slice preparation

All experiments were conducted in accordance with the National Institutes of Health guidelines for the care and use of animals and with an approved animal protocol from the Harvard Medical Area Standing Committee on Animals. Cogenic C57Bl/6 DAT KO (postnatal day 35–60) and their wild-type (WT) littermates were sacrificed and their brains rapidly removed. In cases where drugs were given in vivo via intraperitoneal (i.p.) or subcutaneous (s.c.) injections, mice were sacrificed 30 min following the last dose. Coronal cortical slices (300 μm) containing the anterior cingulated cortex (ACC) and/or the prelimbic (PrL) cortex were cut using a vibratome. Slices were superfused with an ice-cold artificial CSF (ACSF) that contained (in mM): 126 NaCl, 2.5 KCl, 2.5 CaCl2, 1.2 MgCl2, 25 NaHCO3, 1.2 NaH2PO4, and 25 D-glucose. ACSF was saturated with 95% O2 and 5% CO2. Slices were incubated in ACSF for at least 1 hr at room temperature (21–23°C) before transferring to a recording chamber continuously perfused with oxygenated ACSF.

Electrophysiology

Whole-cell voltage- and current-clamp recordings were performed on individual pyramidal neurons under infrared differential interference contrast (DIC) microscopy using an Axoclamp 2B amplifier (Molecular Devices). Pyramidal neurons were identified by their morphology and, in some cases by their characteristic adaptive firing patterns in response to constant current injections. Cortical recordings were made from layer V neurons while presynaptic stimuli (0.033 Hz, 200 μs) were delivered with a concentric bipolar electrode (FHC) placed at layer II/III of the ACC or PrL. For current clamping, electrodes were filled with (in mM) 142 KCl, 8 NaCl, 10 HEPES, 0.4 EGTA, 2 Mg-ATP, 0.25 GTP-Tris, pH 7.25. For evoked excitatory postsynaptic current (EPSC) recordings, neurons were voltage-clamped at −60 mV unless indicated otherwise. 50 μM picrotoxin was present in the superfusion medium to block GABAA receptor-mediated synaptic responses. Tetrodotoxin (1 μM) was added during recordings of miniature EPSCs. Recording pipettes (4.5–5.5 MΩ) were filled with solution containing (in mM): 142 Cs-gluconate, 8 NaCl, 10 HEPES, 0.4 EGTA, 2.5 QX-314, 2 Mg-ATP, 0.25 GTP-Tris, pH 7.25 (with CsOH). Series resistance was monitored throughout whole-cell recordings and data were discarded if the resistance changed by more than 15%. All recordings were made at 32°C with a temperature controller (Warner Instruments). Drugs were delivered to the bath with a gravity-driven perfusion system (Harvard Apparatus). For intracellular dialysis experiments, we waited for at least 10 min after the patch rupture to allow diffusion of the inhibitors.

After obtaining stable EPSCs for 10 min, three different protocols were used to induce LTP: Protocol I involved theta-burst stimulation (TBS; five trains of burst with four pulses at 100 Hz, 200 ms interval; repeated four times at intervals of 10 s). Protocol II involved tetanus stimulation (Tetanus; 100 pulses at 100 Hz). Protocol III involved pairing presynaptic stimulation of 80 pulses at 2 Hz with depolarization of postsynaptic cells at +30 mV. The magnitude of LTP was quantified as the ratio of the averages of 20 EPSCs between 50 and 60 min post LTP induction to the 20 EPSCs collected during the 10 min baseline recording.

We used two methods to measure NMDA/AMPA ratios. In the kinetically based method, 5 EPSCs were recorded first at −60 mV, followed by 5 EPSC recordings at +40 mV. Average EPSCs were computed for each holding potential. The NMDA/AMPA ratio is defined as the amplitude of the NMDAR component 80 ms post-stimulation at +40 mV divided by the peak AMPAR component at −60 mV. In the pharmacologically based method, EPSCs were recorded at +40 mV in the absence (to derive total EPSC) and then the presence (to derive EPSCAMPA) of the NMDAR antagonist AP5 (50 μM). An average of 5 EPSCs were collected and averaged for each EPSC type. EPSCNMDA was isolated by subtracting EPSCAMPA from the total EPSCs. The NMDA/AMPA ratio was then computed.

A PC computer in conjunction with Digidata 1322A and pClamp software (version 9.2, Molecular Devices) were used for data acquisition and analysis. Signals were filtered at 1 kHz and digitized at 10–20 kHz. mEPSCs were analyzed by Mini Analysis 6 (Synaptosoft).

In vivo microdialysis in freely moving mice

In vivo microdialysis experiments were performed as described earlier for striatum in mice (Gainetdinov et al., 2003) with modifications related to PFC analysis (Ihalainen et al., 1999). Briefly, 3 month old mice were anesthetized with ketamine-xylazine mixture, placed in a stereotaxic frame and a dialysis probe (2 mm membrane length, 0.24 mm o.d., Cuprophane, 6 K dalton cut-off, CMA-11, CMA/Microdialysis, Solna, Sweden) was implanted into the right PFC. The stereotaxic coordinates for implantation were (in mm; measured at the probe tip): AP 1.9; DV −3.2; L 0.5 relative to bregma (Paxinos and Franklin, 2001). Placement of the probe was verified by histological examination subsequent to the experiments. After surgery animals were returned to their home cages with free access of food and water. Twenty four hours after insertion of the probe a quantitative “low perfusion rate” microdialysis experiment (Smith et al., 1992; Gainetdinov et al., 2003; Cyr et al., 2006) was conducted in freely moving mice for determination of basal extracellular DA levels in the PFC. The dialysis probe was connected to a syringe pump and perfused at 100 nl/min with an artificial CSF (CMA/Microdialysis, Solna, Sweden) compositing of (in mM): 147 NaCl, 2.7 KCl, 1.2 CaCl2, 0.85 MgCl2. After a minimum 1 hr equilibration period, at least 3 samples were collected every 60 min to a tube containing 2 μl of 0.5 M HCl. Dialysates were analyzed for levels of DA by using high performance liquid chromatography with electrochemical detection (Alexis 100, Antec Leyden, NV Zoeterwoude, Netherlands). DA was separated on a reverse-phase column (ALB-105, 3 μm, 50×1 mm) with a mobile phase consisting of 50 mM phosphate buffer, 8 mM KCl, 500 mg/L octyl sodium sulfate, 0.1 mM EDTA, and 3% methanol (pH 6.0) at a flow rate of 50 μl/min. DA was detected by a Decade II electrochemical detector equipped with two micro VT-03 electrochemical flow cells and 0.7 mm diameter glassy carbon electrode (Alexis 100, Antec Leyden, NV Zoeterwoude, Netherlands). The volume of injection was 5 μl.

Western blot analysis

Mouse (2–3 month old) cortices were rapidly dissected on ice and immediately frozen in liquid nitrogen. Acute cortical slices (300 μm) were stimulated with NMDA (200 μM) or vehicle for 5 min followed by 30 min incubation in oxygenated ACSF. PFC containing ACC and PrL were carefully dissected, snap-frozen in liquid nitrogen, and tissues from individual mice were pooled. Frozen tissues were homogenized in ice-cold buffer containing (in mM) 320 sucrose, 10 Tris-HCl, 5 EDTA, pH 7.4, and centrifuged at 2200 rpm for 10 min to remove large cellular fragments. Membranes were sedimented by centrifugation (15,000 rpm, 30 min, 4°C), re-suspended and sonicated in TE buffer (10 mM Tris-HCl, 5 mM EDTA, pH 7.4), and solubilized in a 1% deoxycholate (DOC) buffer (50 mM Tris-HCl, pH 9.0, 1% sodium deoxycholate). Samples were neutralized in buffer containing 0.1% Triton X-100, 0.1% DOC, 50 mM Tris-HCl, pH 9.0, and centrifuged at 15,000 rpm for 1 hour at 4°C. The supernatant was collected and stored at −80°C until use. Protein kinase inhibitor cocktail (Roche) was present in all buffers. For the detection of phospho-α-CaMKII, a protein phosphatase inhibitor cocktail (Sigma) was present in buffers.

Subcellular fractionation was performed as described previously (Gardoni et al., 2006). Briefly, cortical tissues were homogenized in 0.32 M ice-cold sucrose containing (in mM) 1 HEPES, 1 MgCl2, 1 NaHCO3, 0.1 phenylmethylsulfonyl fluoride (PMSF), and a mixture of protease inhibitors at pH 7.4 and centrifuged at 1000×g for 10 min. The resulting supernatant (S1) was centrifuged at 3000×g for 15 min to obtain crude membrane (P2) and cytosolic (S2) fractions. The pellet (P2) was resuspended in 1 mM HEPES and centrifuged at 100,000×g (1 hr). The pellet (P3) was resuspended in 75 mM KCl containing 1% Triton X-100 and centrifuged at 100,000×g (1 hr). The supernatant (S4) was stored and referred as Triton X-100-soluble fraction (TSF). The insoluble pellet (P4) was homogenized in a glass-glass potter in 20 mM HEPES, glycerol added, giving rise to the Triton-insoluble fraction (TIF). TIF has been shown to be enriched in postsynaptic densities (PSDs, Gardoni et al., 2001; 2006) and was used instead of the classical PSD because of limited amount of the starting material.

Proteins were separated by 10% SDS-PAGE (10–50 μg per lane) and transferred to polyvinylidene difluoride (PDVF) membranes. Blots were immunostained with primary antibodies against NR1 (Upstate), NR2A (Upstate), NR2B (Upstate), NR2A/2B (Chemicon), GluR1 (Upstate), GluR2/3 (Upstate), actin (Millipore), α-CaMKII (Chemicon), or phosphor-Thr286-specific α-CaMKII (Promega) followed by incubation with peroxidase-conjugated goat secondary antibodies. Immunoreactive signals were detected with an ECL-based LAS-3000 image system (Fujifilm). Densitometric analysis was carried out within linear range using ImageGauge (Fujifilm). For each quantification, actin was used as loading controls in which the band densities for the protein to be measured was normalized to the actin band densities from the same loading lanes.

Surface biotinylation

Procedures for biotinylation and analysis of cell surface proteins have been described previously (Zhang et al., 2009; Huang et al., 2009). Acute PFC slices (300 μm) were washed in ice-cold ACSF and incubated in 1 mg/ml NHS-SS-biotin (Pierce) at 4 °C for 30 min (Huang et al., 2009). After a wash in ACSF containing 1 mM lysine, slices were homogenized and sonicated in lysis buffer (in mM) (20 Tris, 50 NaCl, 1% Triton X-100, 0.1% SDS, 1 EDTA, 1 EGTA; pH 7.4) containing proteinase and phosphatase inhibitors. Following mixing at 4°C for 30 min, the homogenates were centrifuged at 14,000 rpm for 15 min at 4°C. The supernatants were quantified by a Micro BCATM Protein Assay (Pierce) and divided into two aliquots. One aliquot was used to determine the total NMDAR subunits by Western blotting. The second aliquot was incubated at 4°C overnight with Neutravidin-linked beads (Pierce) to capture biotinylated surface proteins. After three washes with lysis buffer, the surface proteins were eluted with protein sample buffer containing DTT and subjected to Western blotting.

Drugs

Drugs used and their sources were: ALX5407 (Sigma); AP5 (Sigma); clozapine (Sigma); CNQX (Sigma); D-amphetamine (Sigma); fostriecin (Tocris); GBR12909 (Sigma); haloperidol (Fujisama); KN-93 (Tocris); microsystin LR (Calbiochem); picrotoxin (Sigma); PKI 6–22 (Calbiochem); quinpirole (Sigma); QX-314 (Sigma); raclopride (Sigma); SCH23390 (Tocris); SKF81297 (Sigma); and tetrodotoxin (Sigma).

The concentrations for drugs directly applied in bath were chosen based on their specificity (IC50 or EC50) with related references indicated in Results. The doses for the various DA agonists and antagonists were determined based on published dose response studies on behaviors (e.g. locomotor activity, pre-pulse inhibition, etc.), gene expression (e.g. c-fos activation), and/or signal transduction events (e.g. protein phosphorylation) in mice. The drug/literature specifics are as follows: amphetamine (Ralph et al., 1999); acute and chronic clozapine (Leveque et al., 2000; MacDonald et al., 2005); acute and chronic haloperidol (Usiello et al., 2000; MacDonald et al., 2005); GBR12909 (Salahpour et al., 2008); quinpirole (Halberda et al., 1997); raclopride (Ralph et al., 2001); SCH23390 (Usiello et al., 2000; Ralph et al., 2001); and SKF81297 (Usiello et al., 2000; Gainetdinov et al., 2003).

Statistics

All data are expressed as mean ± SEM. Statistical analysis was carried out using Student's tests, one-way analysis of variance (ANOVA) followed by post hoc Turkey-Kramer tests, or Kolmogorov-Smirnov test, as specified in individual figures.

Results

Prefrontal LTP is absent in DAT KO mice

We examined LTP in layer V pyramidal neurons in slices prepared from mouse mPFC. These neurons receive convergent dopaminergic and glutamatergic inputs, are targets of the hippocampus (Carr and Sesack, 1996), and give rise to massive cortical and subcortical projections (Sesack et al., 1989), thus representing a core element of PFC executive circuits (Williams and Goldman-Rakic, 1995; Seamans and Yang, 2004). These neurons also bear the majority of DA receptors in rodent cortex (Gaspar et al., 1995). We performed whole-cell patch-clamp recordings from visually identified pyramidal neurons in the anterior cingulate or prelimbic cortices, while delivering extracellular stimuli at layer II/III (Fig. 1A).

Figure 1
LTP is abolished in mPFC neurons in DAT KO mice

We identified pyramidal neurons by morphological features or their adaptive firing patterns in response to current injections (Fig. 1B). The EPSCs at these synapses were mediated by glutamate receptors, as they were completely abolished by the AMPA receptor (AMPAR) antagonist CNQX (6-cyano-7-nitroquinoxaline-2,3-dione, 20 μM) and the NMDAR antagonist AP5 (D-2-amino-5-phosphonopentanoic acid, 50 μM) (data not shown). To induce LTP, we used the theta-burst stimulation (TBS) protocol (Tsvetkov et al., 2004; Zhao et al., 2005). TBS consistently produced a robust, long-lasting potentiation of EPSCs in WT (157.1 ± 7.2% of baseline at 50–60 min; Fig. 1C,E). This LTP depended on the activation of NMDARs and Ca2+/CaM-dependent protein kinase II (CaMKII), as it was completely abolished by AP5 (50 μM) and the CaMKII inhibitor KN-93 (20 μM) (Fig. S1). In contrast to WT, no LTP could be elicited in slices prepared from DAT KO mice (102.3 ± 3.9%; Fig. 1D,E).

To examine whether the inability to induce LTP in DAT KO was due to the specific LTP induction paradigm used, we tested two additional protocols. First, the classical tetanus protocol (100 pulses at 100 Hz) produced a significant, long lasting potentiation of EPSCs in WT (166.3 ± 11.7%; Fig. 1F,H), but failed to elicit potentiation in mutant mice (117.2 ± 5.7%; Fig. 1G,H; P < 0.001 vs. WT). Second, pairing low-frequency (2 Hz) presynaptic stimulation with postsynaptic depolarization (+30 mV) produced robust and sustained LTP in WT (155.8 ± 12.1%; Fig. 1I,K), but this LTP was absent in KO slices (111.1 ± 4.0%; Fig. 1J,K; p < 0.001 vs. WT). The pairing protocol bypasses the requirements of intact presynaptic terminal release and spine depolarization mechanisms for LTP induction by high-frequency stimulation protocols. Thus, our data suggest that mechanisms intrinsic to LTP induction in postsynaptic neurons are impaired in the mutant synapses. Taken together, the capability to induce LTP in the PFC was lost in DAT KO mice, regardless of the induction protocols.

Elevated DA levels in PFC impair LTP in mutant and normal mice

To measure the impact of DAT deletion on the “true” basal extracellular concentrations of DA in the PFC, we applied a quantitative “low perfusion rate” microdialysis approach (Smith et al., 1992; Cyr et al., 2006) (Fig. 2A, B). As shown in Fig. 2B, basal DA level in the PFC was markedly (~3.6-fold) higher in DAT KO mice compared to their WT littermates. The enhanced DA tone in the PFC of mutant mice is consistent with a deficient DA clearance mechanism that causes accumulation of DA in the extracellular space in these mice.

Figure 2
Elevation of extracellular DA levels impairs LTP in the PFC

To test whether pharmacological elevation of dopaminergic tone also impairs prefrontal LTP in normal animals, we acutely injected WT mice with various DA agonists and sacrificed the animals 30 min later for LTP assessments. Amphetamine is a potent DA agonist that raises extracellular DA levels in several brain areas including the mouse PFC (Ventura et al., 2004) by blocking and reversing the action of DAT (Amara and Kuhar, 1993). At a psychotomimetic dose (10 mg/kg, i.p.) (Ralph et al., 1999), amphetamine completely abolished prefrontal LTP (Fig. 2D,F) whereas the saline injection was without effect (Fig. 2C, F). Transient elevation of extracellular DA by the selective DAT blocker GBR12909 (10 mg/kg, i.p.; Carboni et al., 2006) also severely impaired LTP induction (Fig. 2E,F). These results suggest that pharmacological treatments that acutely increase prefrontal DA levels in vivo can block induction of PFC LTP. It is thus likely that the absence of LTP in DAT KO mice is due to the hyperdopaminergic tone and less to compensatory mechanisms in the synapse that may be associated with the lack of DAT during development.

Stimulation of D2-class receptors mediates hyperdopaminergic impairment of prefrontal LTP

We next investigated which receptor class might mediate the DA effect in attenuating prefrontal LTP. LTP was unaffected by injections (i.p.) of SKF81297, a full D1 agonist at either moderate (3 mg/kg; Fig. 3A,C) or high (10 mg/kg; Fig. 3B,C) doses. In contrast, stimulation of D2-class receptors by the agonist quinpirole (i.p.) inhibited LTP in a dose-dependent manner (Fig. 3D,E,F). To further investigate the inhibition of D2 overactivation on LTP, we examined LTP in WT slices by including quinpirole in the extracellular recording solution in vitro. Bath applied quinpirole (10 μM) completely abolished prefrontal LTP (Fig. 3G; 95.3 ± 4.2%; P < 0.001 vs. WT). Collectively, these data demonstrate that excessive activation of D2-class receptors is detrimental to LTP induction in the PFC.

Figure 3
D2 stimulation inhibits PFC LTP in normal mice

In DAT KO mice, a sustained hyperdopaminergic tone alters sensitivity of both postsynaptic D1- and D2-class receptors (Gainetdinov et al., 1999). Because D1 class receptor-mediated intracellular signaling classically opposes that mediated by the D2 class, our data suggests that in response to the same elevated DA tone D2-class dominates D1-class receptors in shutting off prefrontal LTP. The blockade of prefrontal LTP by acute amphetamine or GBR12909 administration suggests that this dominance also occurs in normal animals. To further investigate this hypothesis, we injected WT mice with a mixture of SKF81297 and quinpirole to simultaneously stimulate both D1- and D2-class receptors. LTP recorded from slices prepared from these animals was markedly impaired (119.5 ± 3.0%; P < 0.01 vs. WT), mimicking the effect of quinpirole alone (Fig. 3H). Thus, despite their opposite effects in many signaling pathways, D2-class receptors appear to dominate D1-class receptors in the regulation of prefrontal LTP.

Inhibition of D2 receptors rescues prefrontal LTP in DAT KO mice

Given the dominant role of D2 receptors in negatively gating LTP in the PFC, we examined whether antagonizing D2-class receptors could restore LTP in DAT KO mice (Fig. 4). Bath application of haloperidol (10 μM), a typical antipsychotic drug and a potent inhibitor of D2 receptors with relatively high specificity (Seeman and Van Tol, 1994) enabled LTP (Fig. 4A), indicating that D2 inhibition rescued LTP in vitro. More importantly, acute blockade of the D2-class receptors following a single injection (i.p.) of haloperidol (1 mg/kg) similarly rescued LTP in KO mice (Fig. 4B,F), demonstrating that the LTP deficit in the mutant mice can be rescued in vivo. Haloperidol at the same dose had no effect on prefrontal LTP in WT mice, nor did saline injection on LTP in KO mice (Fig. 4F). We also observed similar in vivo rescuing effects of LTP by another selective D2-class antagonist, raclopride (3 mg/kg) (Seeman and Van Tol, 1994) and by the atypical antipsychotic drug clozapine (6 mg/kg; Fig. 4F; Fig. S2). It should be noted that clozapine's pharmacological profile also includes antagonism at D1-class receptors and 5HT2 receptors, and α1-adrenergic receptors (Ereshefsky et al., 1989; Meltzer 1994). The in vivo rescue of LTP by acute D2 blockade in the KO mice (haloperidol, 137.7 ± 6.8%; raclopride, 140.0 ± 10.8%; clozapine, 133.5 ± 9.7%) appeared submaximal when compared to WT (157.1 ± 7.2%) or saline-treated WT (159.6 ± 8.3%) mice. However, chronic exposure to haloperidol (0.5 mg/kg/day, 14 days, Fig. 4E) or clozapine (4 mg/kg/day, 14 days, Fig. S3) completely restored LTP in the mutant mice (Fig. 4F).

Figure 4
Rescue of prefrontal LTP by blockade of D2 receptors in DAT KO mice in vitro and in vivo

Postsynaptic D1-class DA receptors are also dysregulated by the sustained hyperdopaminergic tone in DAT KO mice (Gainetdinov et al., 1999). We found that acute administration of SCH23390 (0.01 mg/kg; s.c.), a D1-class receptor antagonist, to the mutant mice did not rescue LTP (Fig. 4C,F). Furthermore, administration of SKF81297 (3 mg/kg, i.p.) failed to enable LTP (Fig. 4D,F). Thus, despite antagonism of certain aspects of D2-mediated signaling, activation of D1 was unable to mimic the effect of D2 blockade in rescuing LTP in the PFC. These data further support the view that D2 signaling may override D1 signaling under the same hyperdopaminergic condition, blocking LTP.

Altered synaptic transmission in PFC synapses in DAT KO mice

Deficits in basal synaptic properties could prevent LTP induction. For instance, impairment to NMDAR function could inhibit induction of LTP (Kiyama et al., 1998) and saturation of AMPARs, in some cases (Ungless et al., 2001), could occlude LTP induction. Thus, we carried out a detailed characterization of basal synaptic properties in the PFC of DAT KO mice. To evaluate synaptic NMDAR and AMPAR functions, we measured the ratio of NMDAR- to AMPAR-mediated EPSCs (NMDA/AMPA ratio) using two methods. In the kinetics based method, the AMPAR- and NMDAR-mediated components were distinguished by their differential activation and inactivation kinetics (Fig. 5A). In the pharmacology based method, the two components were isolated by recording EPSCs at +40 mV in the absence followed by the presence of AP5 (50 μM) (Fig. 5B). In both cases, the NMDA/AMPA ratio was significantly decreased in DAT KO mice.

Figure 5
Altered synaptic transmission in the PFC of DAT KO and amphetamine-treated mice

The decreased NMDA/AMPA ratio in the mutant synapse could be due to an enhancement in AMPAR number and/or function, a suppression in NMDAR number and/or function, or both. To investigate these possibilities, we analyzed the AMPAR-mediated miniature EPSCs (mEPSCs) (Fig. 5CE). We found no differences in the amplitude of mEPSCs between WT and KO mice (Fig. 5D), suggesting that postsynaptic AMPARs are normal in the mutant mice. In contrast, the frequency of mEPSCs was significantly reduced in KO mice (Fig. 5E). We also found that the paired-pulse ratio (PPR), a reliable measure of transmitter release probability (Zucker, 1989), was significantly increased in the mutant mice at all intervals examined (Fig. 6), suggesting that the glutamatergic terminals in DAT KO mice are impaired. Thus, the reduction in mEPSC frequency likely reflects a decrease in the probability of neurotransmitter release.

Figure 6
Increased paired-pulse facilitation in DAT KO and amphetamine-treated WT mice

The unaltered AMPAR system suggests that the decreased NMDA/AMPA ratio in DAT KO mice was due to a decrease in postsynaptic NMDAR number and/or function. To test this possibility more directly, we analyzed the NMDAR component of mEPSCs. mEPSCs mediated by both AMPARs (mEPSCAMPA) and NMDARs (mEPSCNMDA) were collected in Mg2+-free extracellular solution, and mEPSCAMPA was recorded in the presence of Mg2+ (Fig. 5F). mEPSCNMDA was calculated by subtracting the average mEPSCAMPA from the average total mEPSC and measured as the charge transfer. This analysis showed a significantly reduced mEPSCNMDA in the mutant mice (Fig. 5G), further supporting our conclusion that synaptic NMDAR function is diminished in DAT KO mice.

Redistribution of NMDARs from synaptic to extrasynaptic sites in DAT KO mice

To gain insights into the diminished synaptic NMDAR activity in DAT mutant mice at the molecular level, we performed western blot analysis of glutamate receptors on biochemically fractionated subcellular compartments (Fig. S4). The Triton X-100-insoluble postsynaptic fraction (TIF) is enriched with PSDs and is often used to measure glutamate receptor abundance in the postsynaptic compartment (Gardoni et al., 2001; Picconi et al., 2004; Gardoni et al., 2006). Protein levels of NMDAR and AMPAR subunits in total cortical homogenates were not different between WT and DAT KO mice (Fig. S4C,D), suggesting that expressions of glutamate receptors are largely unaffected in the mutant cortex. However, we observed a significantly reduced NR1, and slight but not significant reduction of NR2A or NR2B, levels in the TIF fraction prepared from DAT KO cortices (Fig. S4E,F), indicating a redistribution of NR1 subunit from insoluble to soluble membrane fractions in DAT KO mice. Because TIF may contain both surface and intracellular proteins, these results do not directly imply trafficking of NMDARs from synaptic to extrasynaptic sites, but do suggest that NMDARs, particularly the obligatory NR1 subunit is redistributed away from the postsynaptic compartment of the synapse.

To further explore the potential trafficking of NMDARs between synaptic and extrasynaptic compartments, we performed cell surface biotinylation experiments on PFC slices (Fig. 7). NHS-SS-biotin binds to free amino groups of proteins and, because it is membrane impermeable, can be used to distinguish between cell surface and intracellular proteins. We found that the surface, but not the total, levels of NR1 and NR2A subunits were significantly reduced in DAT KO mice, whereas NR2B subunits displayed a slight but not statistically significant reduction. These results suggest a redistribution of NR1 and NR2A subunits from surface to intracellular compartments. Together with the TIF experiments, our data support the idea that postsynaptic NMDARs, particularly those containing the NR2A subunit, may have been removed from the synapse under hyperdopaminergic conditions.

Figure 7
Reduced surface NMDAR receptors in DAT KO mice as analyzed by surface biotinylation

Amphetamine acutely mimics synaptic deficits in DAT KO mice

To exclude the possibility that the synaptic deficits observed in DAT KO mice might be related to non-specific adaptive or compensatory changes associated with the constitutive DAT deletion during development, we repeated the electrophysiological analyses in amphetamine-treated WT mice. Acute single injection of amphetamine (10 mg/kg, i.p.) reduced the NMDA/AMPA ratio (Fig. 5A), diminished the mEPSC frequency (Fig. 5C,E), increased PPR (Fig. 6), and suppressed mEPSCNMDA (Fig. 5G). These data recapitulated the synaptic deficiencies observed in DAT KO mice, further supporting the role of elevated DA tone per se in the synaptic transmission abnormalities in these hyperdopaminergic models.

Normalizing NMDAR function does not fully restore prefrontal LTP

We next investigated the synaptic mechanism that underlies the loss of LTP in the PFC synapse of DAT KO mice. Since prefrontal LTP depends upon the activation of NMDARs (Fig. S1), we first tested whether the LTP deficit might result from hypofunctional NMDARs. For this purpose, prefrontal LTP was evaluated in DAT KO slices under a condition in which the compromised NMDAR function was pharmacologically normalized. ALX5407, a selective inhibitor of the glycine transporter, functions as an indirect glycine site NMDAR agonist (Atkinson et al., 2001). ALX5407 (1 μM, Konradsson et al., 2006) did not have significant effect on NMDA/AMPA ratio in WT, but completely restored the ratio in KO mice (Fig. 8A,B). This restoration occurred in the absence of any modulation of EPSCAMPA (Fig. 8C), suggesting that ALX5407 normalized NMDAR function in the KO mice. We then examined whether ALX5407 could restore LTP in the mutant synapse. We found that bath application of ALX5407 only partially rescued prefrontal LTP in the mutant mice (135.4 ± 7.6%, p < 0.05, vs. WT, or ~62% of WT control; Fig. 8D, ,9E),9E), and had no effect on LTP in WT synapses (Fig. 9E). Thus, while hypofunctional NMDARs may contribute to the LTP deficiency in the KO mice, additional mechanisms must be involved.

Figure 8
Normalizing NMDARs or inhibiting postsynaptic PP1 independently rescues prefrontal LTP in DAT KO mice
Figure 9
Rescue of prefrontal LTP by D2 blockage depends on postsynaptic PP1 signaling but not NMDAR modulation

Inhibition of postsynaptic PP1 rescues prefrontal LTP independent of NMDAR modulation

We explored the hypothesis that PP1, a protein phosphatase enriched in the PSD (Shields et al., 1985), may be involved in PFC LTP. PP1 can gate hippocampal LTP by regulating the activity of its substrate, CaMKII in postsynaptic neurons (Blitzer et al., 1995). Overactivation of D2-class receptors in response to hyperdopaminergic tone may elevate PP1 activity by antagonizing this cAMP/PKA cascade or by triggering other Ca2+ dependent signaling modules, e.g. the calcineurin (PP-2B) (Greengard et al., 1999), preventing induction of LTP. Consistent with this idea, we found that the total level of α-CaMKII was normal, but the phosphorylation of α-CaMKII at Thr286 was markedly reduced in the cortex of DAT KO mice compared to WT littermates. In addition, NMDA-stimulated α-CaMKII phosphorylation was lost in the mutant slices (Fig. S5). These results suggest that cortical PP1 activity is constitutively elevated in DAT KO mice.

To investigate whether the overactivation of postsynaptic PP1 contributes to the LTP failure in DAT KO mice, we tested the effect of PP1 inhibition on LTP induction. Loading postsynaptic cells with microcystin LR (10 μM) (Launey et al., 2004; Belmeguenai and Hansel, 2005), a potent inhibitor of PP1/PP2A, restored LTP in DAT KO slices (Fig. 8E). In contrast, loading cells with the PP2A-specific inhibitor fostriecin (100 nM) (Belmeguenai and Hansel, 2005; Launey et al., 2004) was without effect (Fig. 8H, ,9E).9E). Thus, the rescue of LTP by microcystin LR in DAT KO cells was mediated principally by inhibition of PP1. Microcystin LR had little effect on LTP in WT neurons (Fig. 9E), indicating that the endogenous PP1 activity in the synapse under normal conditions is sufficiently low so that its additional inhibition would not further facilitate LTP. Microcystin LR loading affected neither EPSCAMPA nor EPSCNMDA (Fig. 8F,G), consistent with a previous report that PP1 does not affect basal synaptic strength (Morishita et al., 2001). Our data exclude the possibility that the LTP enabling by PP1 inhibition was mediated by PP1 modification of NMDA and/or AMPA receptors, and support the notion that during LTP induction, PP1 gains access to synaptic substrates whose activity, or lack thereof, is critical for LTP.

If the PP1-dependent rescue of prefrontal LTP in mutant synapses was independent of NMDAR modifications as a consequence of PP1 inhibition, NMDAR normalization and PP1 inhibition should result in LTP that is greater than either manipulation alone. Indeed, bath-applied ALX5407 elicited additional LTP in cells postsynaptically loaded with microcystin (Fig. 8I, ,9E),9E), supporting the idea that the NMDAR- and PP1-dependent rescues of PFC LTP in mutant synapses are additive. Thus, the loss of PFC LTP in DAT KO mice is likely mediated by two separable mechanisms, hypofunctional NMDARs and hyperactive PP1 signaling.

LTP rescue by D2 receptor blockade is mediated by postsynaptic PP1

We finally determined which of the mechanisms, the NMDAR hypofunction or the PP1 hyperactivation, mediates the D2-dependent rescue of prefrontal LTP. We found that a single injection of haloperidol did not significantly affect the NMDA/AMPA ratio in both WT and KO mice (Fig. 8A,B), suggesting that haloperidol-restored LTP was independent of NMDAR modification. In contrast, loading cells with PKI (6–22) (20 μM; Yasuda et al., 2003), a membrane-impermeable inhibitory peptide of PKA, prevented LTP in slices prepared from haloperidol-treated DAT KO mice (Fig. 9A). Because the D2-mediated PP1 signaling can presumably be blocked by inhibition of the downstream PKA in postsynaptic cells, these data suggest that blocking D2 receptors rescued LTP via suppression of the postsynaptic PP1 signaling. In support of this interpretation, we found that loading cells with microcystin LR (10 μM) in slices from haloperidol-treated mice resulted in LTP (135.2 ± 11.7%) that was comparable to LTP rescued by either PP1 inhibition (141.5 ± 8.3%) or haloperidol (137.7 ± 6.8%) alone (Fig. 9E). In contrast, incubation of slices prepared from haloperidol-treated DAT KO mice in the presence of ALX5407 (1 μM) resulted in LTP (157.3 ± 5.9%) that was significantly greater than LTP enabled by either ALX5407 (135.4 ± 7.6%) or haloperidol (Fig. 9C, E). Finally, if D2 receptors “gate” LTP via regulating the activity of PP1, constitutive suppression of PP1 should permit LTP even when D2 is excessively activated. Indeed, we observed that loading cells with microcystin LR (10 μM) prevented the quinpirole-induced inhibition of LTP (Fig. 9D,E). Together, our findings demonstrate that postsynaptic D2 receptors tightly couple to the PP1 signaling, rather than NMDAR activity, in postsynaptic cells to control LTP induction in the PFC.

Discussion

In this study, we show that excessive DA tone impairs induction of LTP in the PFC. Although presynaptic contributions can not be excluded, the LTP blockade can be mediated by overstimulation of postsynaptic D2-class receptors that results in elevated postsynaptic PP1 activity via a heterosynaptic gating mechanism (Fig. 10). Excessive PP1 activity may keep an abnormally large portion of synaptic CaMKII unphosphorylated, locking the bistable CaMKII/PP1 switch in the “OFF” state refractory to activation by NMDARs during LTP induction, thus preventing LTP (Lisman and Zhabotinsky, 2001).

Figure 10
Working models for homosynaptic vs. heterosynaptic gating of LTP in postsynaptic neurons

Dopaminergic modulation of prefrontal transmission and plasticity

It is believed that DA transmission plays a permissive or facilitating role in LTP in the PFC. In slices, activation of D1-class receptors enhances, and blockade of them attenuates the late, protein synthesis-dependent maintenance phase of LTP in layer V prefrontal synapses; blockade of D2-class receptors is without effect (Huang et al., 2004). Background or phased DA has also been shown to facilitate LTP induction (Blond et al., 2002; Matsuda et al., 2006). Similar facilitating effects of DA on LTP have been observed in anesthetized (Gurden et al., 1999; Gurden et al., 2000) and behaving animals performing learning tasks (Li et al., 2003; Lemon and Manahan-Vaughan, 2006). The dopaminergic facilitation of LTP is thought to be achieved by DA released during LTP induction and is, in most cases, mediated through the cAMP/PKA signaling (Jay et al., 1998; Gurden et al., 2000; Otani et al., 2003; Huang et al., 2004). These studies highlight the role of phasic DA and postsynaptic D1-, but not D2-, class receptors in promoting synaptic plasticity.

Overactive dopaminergic signaling is implicated in prefrontal dysfunctions associated with schizophrenia, ADHD, and stress (Seeman, 1987; Goldman-Rakic, 1995; Castellanos and Tannock, 2002; Arnsten, 2009). How elevated DA tone affects LTP, and synaptic transmission in the PFC in general, has not been investigated. Using a genetic model of hyperdopaminergia, we demonstrate that elevated DA tone acts at the D2-class receptors to impair prefrontal LTP through increasing the postsynaptic PP1 activity. In addition, the hyperdopaminergic tone impairs at least two other synaptic mechanisms. First, glutamate release at glutamatergic terminals (Fig. 6), as well as DA release/clearance at dopaminergic terminals (Jones et al., 1998), are impaired in the KO mice. Second, postsynaptic NMDARs are diminished. This diminishment is mediated, at least in part, by the removal of NR2A-containing NMDARs from mutant synapses, as suggested by the subcellular fractionation and surface biotinylation experiments. Since TIF and PSD contain both surface and intracellular proteins, the decreased NR1 level in TIF simply suggests a reduced availability of this NMDAR obligatory subunit in the postsynaptic compartment, and does not necessarily suggest a reduction or subunit dysregulation of assembled NMDARs at the surface. On the other hand, the selective reduction of surface, but not total, NR1 and NR2A subunits in mutant mice suggests that NR1/NR2A NMDARs are removed from the surface pool. Assuming that synaptic and nonsynaptic surface receptors (extrasynaptic) are uniformly affected, this result, together with the postsynaptic TIF data, strongly suggests a redistribution of postsynaptic NMDARs, especially those containing NR2A from synaptic to nonsynaptic sites under hyperdopaminergic conditions. Redistribution of NMDAR subunits between synaptic and extrasynaptic compartments has been shown to be highly sensitive to DA signaling and psychostimulant action, and can be mediated by a number of mechanisms, including phosphorylation, ubiquitination, and scaffolding (Dunah and Standaet, 2001; Gardoni et al., 2006; Hallett et al., 2006; Schilström et al., 2006; Gao and Wolf, 2008; Huang et al., 2009; Mao et al., 2009). Further experiments are needed to elucidate the mechanisms underlying redistribution of NMDAR subunits in response to elevated DA tone.

Our quantitative microdialysis experiments demonstrate that extracellular levels of DA in the PFC of DAT KO are increased by about 3.6 fold from 2.2 nM in WT to 7.9 nM in KO mice. These direct measurements support earlier indirect indications of altered DA function in the frontal cortex of these mice, such as blunted tissue levels of DA and its extracellular metabolite homovanillic acid (Pogorelov et al., 2005). Notably, in the striatum of DAT KO mice extracellular DA is increased by about 5 fold from 7–10 nM in WT mice to 35–45 nM in KO mice (Jones et al., 1998; Cyr et al., 2006). Given the relatively low level of DAT expression in the cortex (Freed et al., 1995; Sesack et al., 1998), it might be expected that the impact of DAT deletion on DA dynamics in the PFC could be significantly less than what we observed here. A potential explanation for this observation could be that striatal and accumbal DA may spillover (leak) to neighboring regions thus elevating DA levels in regions that normally have very low levels of extracellular DA. In fact, it has been estimated that DA released to striatal neurons of DAT KO mice can diffuse for millimeters thus affecting large populations of neurons via “volume transmission” (Jones et al., 1998). It should be noted also that the effect of the trauma layer in the tissue surrounding the microdialysis probe on the amount of DA recovered in dialysates (Bungay et al., 2003, Borland et al., 2005) might differ in WT and DAT KO mice, which may potentially contribute to the difference in DA levels observed between genotypes.

Several lines of evidence presented here support the view that the synaptic deficits in DAT KO mice are likely direct consequences of the high DA tone. First, total levels of cortical NMDAR and AMPAR subunits are unaltered in the KO mice. Second, acute suppression of postsynaptic PP1 mimics and occludes the D2-mediated rescue of LTP in KO mice, which together with an acute pharmacological normalization of NMDAR activity, fully restores LTP in the mutant mice. Finally, a single injection of amphetamine to WT mice recapitulates the synaptic deficits in the KO mice. These findings suggest that the elevated extracellular DA and dysregulation of downstream DA signaling are largely responsible for the synaptic transmission and plasticity abnormalities associated with the sustained hyperdopaminergia.

Our findings do not diminish the importance of D1 receptors in LTP induction, but rather reveal a previously unrecognized inhibitory role for D2-class receptors that becomes dominant under abnormal, hyperdopaminergic conditions. Although both classes of receptors are localized on distal dendrites and spines of layer V PFC pyramidal neurons, D1 receptors significantly outnumber D2 receptors (Gaspar et al., 1995). Thus, the overriding role of D2 receptors may seem surprising. The D2 dominance in this synapse may reflect a more enriched representation of the signaling component(s) within D2-coupled signaling cascades. For instance, Giα, a G protein subunit that inhibits adenylyl cyclase, is considerably more abundant than the adenylyl cyclase-stimulating Goα, in cortical postsynaptic densities (Wu et al., 1992). Alternatively, a compartmentalized, D2-specific signaling system tightly coupled to the LTP induction machinery in the synapse may account for the D2 dominance. Regardless of the mechanism, our studies identify an important prefrontal process highly sensitive to D2 dysregulation.

A constitutive heterosynaptic PP1 gate for LTP induction in the PFC

Postsynaptic PP1 plays a gating role in LTP induction in hippocampal CA1 neurons (Blitzer et al., 1995). Certain LTP stimulation patterns activate not only protein kinases necessary for LTP induction, but also postsynaptic phosphatases that oppose the induction (O'Dell and Kandel, 1994; Blitzer et al., 1995). Under such conditions, the transient surge of phosphatase activity needs to be suppressed to permit LTP induction. This is presumably achieved through a signaling cascade that involves activation of synaptic NMDARs, influx of Ca2+, stimulation of Ca2+-sensitive adenylyl cyclases, rise of intraspine cAMP, activation of PKA, and stimulation of I-1, leading to inhibition of PP1 that maintains CaMKII at the phosphorylation state necessary for LTP induction (Fig. 10A) (Blitzer et al., 1995). This gating occurs during LTP induction within activated synapses, thus can be regarded as a transient, activity-dependent homosynaptic gate for LTP (Fig. 10A).

Our studies suggest that a PP1 gate can also be operated by heterosynaptic dopaminergic systems (Fig. 10B). The localization of DA receptors in cortical triads that receive both glutamatergic and dopaminergic innervations provides the anatomical basis for a heterosynaptic modulation of excitatory transmission and plasticity at individual cortical synapses by DA. Key components that mediate DA signaling, e.g. PKA and their anchoring proteins, Ca2+-responsive signaling molecules, and major protein phosphatases are also well represented in dendritic spines (Jordan et al., 2004; Li et al., 2004; Peng et al., 2004). Although the precise signaling intermediates that link D2 stimulation and PP1 activation in the synapse leading to LTP erosion remains to be determined, activation of spine D2-class receptors can presumably elevate postsynaptic PP1 activity through inhibition of the cAMP/PKA-dependent signaling, activation of the Ca2+-dependent calcineurin signaling, and/or other unidentified pathways. In principle, stimulation of spine D1-class receptors, and perhaps other neuromodulatory receptors, can activate the cAMP/PKA pathway and suppress the postsynaptic PP1 activity, opposing the D2 signaling. Despite the competing D1 and D2 signaling, the augmented PP1 activity in mutant PFC synapses suggests that, in response to a same excessive DA tone, the D2-mediated PP1 activation overrides the D1-mediated PP1 suppression.

This heterosynaptic gating differs mechanistically from homosynaptic gating. The homosynaptic gate is operated by NMDARs, occurs during the transient induction phase of LTP, and manifests under certain patterns of synaptic stimulation that activate protein phosphatases. Ca2+-stimulated adenylyl cyclases are presumably required to trigger the cAMP/PKA-dependent signaling to maintain an open gate. In contrast, the heterosynaptic gating illustrated here is operated by DA receptors, occurs constitutively due to the continuous presence of background DA tone, does not depend on Ca2+-sensitive adenylyl cyclases, and may influence LTP induction by any protocols. The failure to induce LTP in DAT KO mice by all three protocols tested (TBS, tetanus, and pairing), none of which are thought to activate phosphatases, is consistent with this idea. In addition, the sustained elevation of postsynaptic PP1 activity and a concomitant ~30% reduction of the basal phosphorylation of α-CaMKII, a substrate of synaptic PP1, in the KO mice supports the constitutive nature of the gate.

In summary, our data uncover a mechanism by which excessively elevated DA tone impairs LTP in the mouse mPFC, considered a homologue to the primate dorsolateral PFC (Kolb and Cioe, 2004) that is important for higher-order cognitive functions including working memory (Goldman-Rakic, 1995). Recent work has also implicated the mPFC in remote spatial and contextual memory storage (Frankland et al., 2004; Maviel et al., 2004). By abolishing LTP in the mPFC, excessive DA may inhibit encoding and storage of lasting memory traces in this region and impair related behaviors that depend on these memories. Consistent with this view, DAT KO mice display several cognitive deficits, including spatial learning, behavioral flexibility, and the ability to suppress inappropriate responses (Gainetdinov et al., 1999; Morice et al., 2007; Weiss et al., 2007; Dzirasa et al., 2009). In addition, although the beneficial effects of stimulants in improving attention and cognition have been well recognized, it is now clear that high doses of amphetamine impair prefrontal cognitive functions (Arnsten, 2006; Ko and Evenden, 2009; Wood and Ananostaras, 2009). The detrimental effects are often characterized as inverted-U actions of DA mediated by superanomal stimulation of D1-class receptors (Zahrt et al., 1997; Seamans and Yang, 2004; Vijayraghavan et al., 2007). Here we show that high dose amphetamine abolishes PFC LTP via a D2 receptor-coupled phosphatase gating mechanism. These findings represent a novel mechanism by which excessive DA could impair prefrontal cognitive functions via D2 receptors, in addition to the inverted-U shaped D1 receptor-mediated mechanism.

Supplementary Material

Supp1

Acknowledgements

We thank Dr. Marc G. Caron for the DAT KO mice. We thank members of the Division of Neuroscience at NEPRC for discussions. This work was supported by a National Center for Research Resources grant RR000168 (to the New England Primate Research Center), National Institute of Health grants DA021420 and NS057311 (W.-D.Y.), DA011059, DA011928, DA017700, and DA024315 (R.D.S.), a National Alliance for Research on Schizophrenia and Depression Young Investigator Award, and Williams F. Milton Fund of Harvard University (to W.-D.Y.).

References

  • Amara SG, Kuhar MJ. Neurotransmitter transporters: recent progress. Annu Rev Neurosci. 1993;16:73–93. [PubMed]
  • Arnsten AF. Stimulants: Therapeutic actions in ADHD. Neuropsychopharmacology. 2006;31:2376–2383. [PubMed]
  • Arnsten AF. Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci. 2009;10:410–422. [PMC free article] [PubMed]
  • Atkinson BN, Bell SC, De Vivo M, Kowalski LR, Lechner SM, Ognyanov VI, Tham CS, Tsai C, Jia J, Ashton D, Klitenick MA. ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter. Mol Pharmacol. 2001;60:1414–1420. [PubMed]
  • Belmeguenai A, Hansel C. A role for protein phosphatases 1, 2A, and 2B in cerebellar long-term potentiation. J Neurosci. 2005;25:10768–10772. [PubMed]
  • Blitzer RD, Wong T, Nouranifar R, Iyengar R, Landau EM. Postsynaptic cAMP pathway gates early LTP in hippocampal CA1 region. Neuron. 1995;15:1403–1414. [PubMed]
  • Blond O, Crepel F, Otani S. Long-term potentiation in rat prefrontal slices facilitated by phased application of dopamine. Eur J Pharmacol. 2002;438:115–116. [PubMed]
  • Borland LM, Shi G, Yang H, Michael AC. Voltammetric study of extracellular dopamine near microdialysis probes acutely implanted in the striatum of the anesthetized rat. J Neurosci Methods. 2005;146:149–158. [PubMed]
  • Bungay PM, Newton-Vinson P, Isele W, Garris PA, Justice JB. Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma. J Neurochem. 2003;86:932–946. [PMC free article] [PubMed]
  • Gao C, Wolf ME. Dopamine receptors regulate NMDA receptor surface expression in prefrontal cortex neurons. J Neurochem. 2008;106:2489–2501. [PMC free article] [PubMed]
  • Carboni E, Silvagni A, Vacca C, Di Chiara G. Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex. J Neurochem. 2006;96:473–481. [PubMed]
  • Carr DB, Sesack SR. Hippocampal afferents to the rat prefrontal cortex: synaptic targets and relation to dopamine terminals. J Comp Neurol. 1996;369:1–15. [PubMed]
  • Castellanos FX, Tannock R. Neuroscience of attention-deficit hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci. 2002;3:617–628. [PubMed]
  • Cyr M, Sotnikova TD, Gainetdinov RR, Caron MG. Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin. FASEB J. 2006;20:2541–2543. [PubMed]
  • Dunah AW, Standaert DG. Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. J Neurosci. 2001;21:5546–5558. [PubMed]
  • Dzirasa K, Ramsey AJ, Takahashi DY, Stapleton J, Potes JM, Williams JK, Gainetdinov RR, Sameshima K, Caron MG, Nicolelis MA. Hyperdopaminergia and NMDA receptor hypofunction disrupt neural phase signaling. J Neurosci. 2009;29:8215–8224. [PMC free article] [PubMed]
  • Ereshefsky L, Watanabe MD, Tran-Johnson TK. Clozapine: an atypical antipsychotic agent. Clin Pharm. 1989;8:691–709. [PubMed]
  • Frankland PW, Bontempi B, Talton LE, Kaczmarek L, Silva AJ. The involvement of the anterior cingulate cortex in remote contextual fear memory. Science. 2004;304:881–883. [PubMed]
  • Freed C, Revay R, Vaughan RA, Kriek E, Grant S, Uhl GR, Kuhar MJ. Dopamine transporter immunoreactivity in rat brain. J Comp Neurol. 1995;359:340–349. [PubMed]
  • Fuster JM. Frontal Lobes. Curr Opin Neurobiol. 1993;3:160–165. [PubMed]
  • Gainetdinov RR, Jones SR, Caron MG. Functional hyperdopaminergia in dopamine transporter knock-out mice. Biol Psychiatry. 1999;46:303–311. [PubMed]
  • Gainetdinov RR, Bohn LM, Sotnikova TD, Cyr M, Laakso A, Macrae AD, Torres GE, Kim KM, Lefkowitz RJ, Caron MG, Premont RT. Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron. 2003;38:291–303. [PubMed]
  • Gardoni F, Picconi B, Ghiglieri V, Polli F, Bagetta V, Bernardi G, Cattabeni F, Di Luca M, Calabresi P. A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. J Neurosci. 2006;26:2914–2922. [PubMed]
  • Gardoni F, Schrama LH, Kamal A, Gispen WH, Cattabeni F, Di Luca M. Hippocampal synaptic plasticity involves competition between Ca2+/calmodulin-dependent protein kinase II and postsynaptic density 95 for binding to the NR2A subunit of the NMDA receptor. J Neurosci. 2001;21:1501–1509. [PubMed]
  • Gaspar P, Bloch B, Le Moine C. D1 and D2 receptor gene expression in the rat frontal cortex: cellular localization in different classes of efferent neurons. Eur J Neurosci. 1995;7:1050–1063. [PubMed]
  • Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 1996;379:606–612. [PubMed]
  • Goldman-Rakic PS. Cellular basis of working memory. Neuron. 1995;14:477–485. [PubMed]
  • Goldman-Rakic PS, Leranth C, Williams SM, Mons N, Geffard M. Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc Natl Acad Sci U S A. 1989;86:9015–9019. [PubMed]
  • Greengard P, Allen PB, Nairn AC. Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron. 1999;23:435–447. [PubMed]
  • Gurden H, Tassin JP, Jay TM. Integrity of the mesocortical dopaminergic system is necessary for complete expression of in vivo hippocampal-prefrontal cortex long-term potentiation. Neuroscience. 1999;94:1019–1027. [PubMed]
  • Gurden H, Takita M, Jay TM. Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo. J Neurosci. 2000;20:RC106. [PubMed]
  • Halberda JP, Middaugh LD, Gard BE, Jackson BP. DAD1- and DAD2-like agonist effects on motor activity of C57 mice: differences compared to rats. Synapse. 1997;26:81–92. [PubMed]
  • Hirsch JC, Crepel F. Blockade of NMDA receptors unmasks a long-term depression in synaptic efficacy in rat prefrontal neurons in vitro. Exp Brain Res. 1991;85:621–624. [PubMed]
  • Hirsch JC, Crepel F. Postsynaptic calcium is necessary for the induction of LTP and LTD of monosynaptic EPSPs in prefrontal neurons: an in vitro study in the rat. Synapse. 1992;10:173–175. [PubMed]
  • Huang YH, Lin Y, Mu P, Lee BR, Brown TE, Wayman G, Marie H, Liu W, Yan Z, Sorg BA, Schlüter OM, Zukin RS, Dong Y. In vivo cocaine experience generates silent synapses. Neuron. 2009;63:40–47. [PMC free article] [PubMed]
  • Huang YY, Simpson E, Kellendonk C, Kandel ER. Genetic evidence for the bidirectional modulation of synaptic plasticity in the prefrontal cortex by D1 receptors. Proc Natl Acad Sci U S A. 2004;101:3236–3241. [PubMed]
  • Ihalainen JA, Riekkinen P, Jr., Feenstra MG. Comparison of dopamine and noradrenaline release in mouse prefrontal cortex, striatum and hippocampus using microdialysis. Neurosci Lett. 1999;277:71–74. [PubMed]
  • Jay TM, Burette F, Laroche S. NMDA receptor-dependent long-term potentiation in the hippocampal afferent fibre system to the prefrontal cortex in the rat. Eur J Neurosci. 1995;7:247–250. [PubMed]
  • Jay TM, Gurden H, Yamaguchi T. Rapid increase in PKA activity during long-term potentiation in the hippocampal afferent fibre system to the prefrontal cortex in vivo. Eur J Neurosci. 1998;10:3302–3306. [PubMed]
  • Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci U S A. 1998;95:4029–4034. [PubMed]
  • Jordan BA, Fernholz BD, Boussac M, Xu C, Grigorean G, Ziff EB, Neubert TA. Identification and verification of novel rodent postsynaptic density proteins. Mol Cell Proteomics. 2004;3:857–871. [PubMed]
  • Kauer JA, Malenka RC. Synaptic plasticity and addiction. Nat Rev Neurosci. 2007;8:844–858. [PubMed]
  • Kiyama Y, Manabe T, Sakimura K, Kawakami F, Mori H, Mishina M. Increased thresholds for long-term potentiation and contextual learning in mice lacking the NMDAtype glutamate receptor epsilon1 subunit. J Neurosci. 1998;18:6704–6712. [PubMed]
  • Ko T, Evenden J. The effects of psychotomimetic and putative cognitive-enhancing drugs on the performance of a n-back working memory task in rats. Psychopharmacology (Berl) 2009;202:67–78. [PubMed]
  • Kolb B, Cioe J. Organization and Plasticity of the Prefrontal Cortex of the Rat. In: Otani S, editor. Prefrontal cortex: From synaptic plasticity to cognition. Kluwer Academic Publishers; 2004. pp. 1–32.
  • Konradsson A, Marcus MM, Hertel P, Svensson TH, Jardemark KE. Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex. Synapse. 2006;60:102–108. [PubMed]
  • Launey T, Endo S, Sakai R, Harano J, Ito M. Protein phosphatase 2A inhibition induces cerebellar long-term depression and declustering of synaptic AMPA receptor. Proc Natl Acad Sci U S A. 2004;101:676–681. [PubMed]
  • Lemon N, Manahan-Vaughan D. Dopamine D1/D5 receptors gate the acquisition of novel information through hippocampal long-term potentiation and long-term depression. J Neurosci. 2006;26:7723–7729. [PubMed]
  • Leveque JC, Macias W, Rajadhyaksha A, Carlson RR, Barczak A, Kang S, Li XM, Coyle JT, Huganir RL, Heckers S, Konradi C. Intracellular modulation of NMDA receptor function by antipsychotic drugs. J Neurosci. 2000;20:4011–4020. [PubMed]
  • Li KW, Hornshaw MP, Van Der Schors RC, Watson R, Tate S, Casetta B, Jimenez CR, Gouwenberg Y, Gundelfinger ED, Smalla KH, Smit AB. Proteomics analysis of rat brain postsynaptic density. Implications of the diverse protein functional groups for the integration of synaptic physiology. J Biol Chem. 2004;279:987–1002. [PubMed]
  • Li S, Cullen WK, Anwyl R, Rowan MJ. Dopamine-dependent facilitation of LTP induction in hippocampal CA1 by exposure to spatial novelty. Nat Neurosci. 2003;6:526–531. [PubMed]
  • Lidow MS, Goldman-Rakic PS, Gallager DW, Rakic P. Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390. Neuroscience. 1991;40:657–671. [PubMed]
  • Lisman JE, Zhabotinsky AM. A model of synaptic memory: a CaMKII/PP1 switch that potentiates transmission by organizing an AMPA receptor anchoring assembly. Neuron. 2001;31:191–201. [PubMed]
  • MacDonald ML, Eaton ME, Dudman JT, Konradi C. Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat. Biol Psychiatry. 2005;57:1041–1051. [PMC free article] [PubMed]
  • Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron. 2004;44:5–21. [PubMed]
  • Matsuda Y, Marzo A, Otani S. The presence of background dopamine signal converts long-term synaptic depression to potentiation in rat prefrontal cortex. J Neurosci. 2006;26:4803–4810. [PubMed]
  • Maviel T, Durkin TP, Menzaghi F, Bontempi B. Sites of neocortical reorganization critical for remote spatial memory. Science. 2004;305:96–99. [PubMed]
  • McClelland JL, McNaughton BL, O'Reilly RC. Why there are complementary learning systems in the hippocampus and neocortex: insights from the successes and failures of connectionist models of learning and memory. Psychol Rev. 1995;102:419–457. [PubMed]
  • Meltzer HY. An overview of the mechanism of action of clozapine. J Clin Psychiatry. 1994;55(Suppl B):47–52. [PubMed]
  • Morice E, Billard JM, Denis C, Mathieu F, Betancur C, Epelbaum J, Giros B, Nosten-Bertrand M. Parallel loss of hippocampal LTD and cognitive flexibility in a genetic model of hyperdopaminergia. Neuropsychopharmacology. 2007;32:2108–2116. [PMC free article] [PubMed]
  • Morishita W, Connor JH, Xia H, Quinlan EM, Shenolikar S, Malenka RC. Regulation of synaptic strength by protein phosphatase 1. Neuron. 2001;32:1133–1148. [PubMed]
  • O'Dell TJ, Kandel ER. Low-frequency stimulation erases LTP through an NMDA receptor-mediated activation of protein phosphatases. Learn Mem. 1994;1:129–139. [PubMed]
  • Otani S, Daniel H, Roisin MP, Crepel F. Dopaminergic modulation of long-term synaptic plasticity in rat prefrontal neurons. Cereb Cortex. 2003;13:1251–1256. [PubMed]
  • Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. Ed 4 Academic Press; San Diego: 2001.
  • Peng J, Kim MJ, Cheng D, Duong DM, Gygi SP, Sheng M. Semiquantitative proteomic analysis of rat forebrain postsynaptic density fractions by mass spectrometry. J Biol Chem. 2004;279:21003–21011. [PubMed]
  • Picconi B, Gardoni F, Centonze D, Mauceri D, Cenci MA, Bernardi G, Calabresi P, Di Luca M. Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. J Neurosci. 2004;24:5283–5291. [PubMed]
  • Pogorelov VM, Rodriguiz RM, Insco ML, Caron MG, Wetsel WC. Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene. Neuropsychopharmacology. 2005;30:1818–1831. [PubMed]
  • Ralph RJ, Paulus MP, Fumagalli F, Caron MG, Geyer MA. Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists. J Neurosci. 2001;21:305–313. [PubMed]
  • Ralph RJ, Varty GB, Kelly MA, Wang YM, Caron MG, Rubinstein M, Grandy DK, Low MJ, Geyer MA. The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J Neurosci. 1999;19:4627–4633. [PubMed]
  • Salahpour A, Ramsey AJ, Medvedev IO, Kile B, Sotnikova TD, Holmstrand E, Ghisi V, Nicholls PJ, Wong L, Murphy K, Sesack SR, Wightman RM, Gainetdinov RR, Caron MG. Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter. Proc Natl Acad Sci U S A. 2008;105:4405–4410. [PubMed]
  • Schilström B, Yaka R, Argilli E, Suvarna N, Schumann J, Chen BT, Carman M, Singh V, Mailliard WS, Ron D, Bonci A. Cocaine enhances NMDA receptor-mediated currents in ventral tegmental area cells via dopamine D5 receptor-dependent redistribution of NMDA receptors. J Neurosci. 2006;26:8549–8558. [PubMed]
  • Seamans JK, Yang CR. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol. 2004;74:1–58. [PubMed]
  • Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse. 1987;1:133–152. [PubMed]
  • Seeman P, Van Tol HH. Dopamine receptor pharmacology. Trends Pharmacol Sci. 1994;15:264–270. [PubMed]
  • Sesack SR, Deutch AY, Roth RH, Bunney BS. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol. 1989;290:213–242. [PubMed]
  • Sesack SR, Hawrylak VA, Guido MA, Levey AI. Cellular and subcellular localization of the dopamine transporter in rat cortex. Adv Pharmacol. 1998;42:171–174. [PubMed]
  • Shields SM, Ingebritsen TS, Kelly PT. Identification of protein phosphatase 1 in synaptic junctions: dephosphorylation of endogenous calmodulin-dependent kinase II and synapse-enriched phosphoproteins. J Neurosci. 1985;5:3414–3422. [PubMed]
  • Smith AD, Olson RJ, Justice JB., Jr. Quantitative microdialysis of dopamine in the striatum: effect of circadian variation. J Neurosci Methods. 1992;44:33–41. [PubMed]
  • Squire LR, Alvarez P. Retrograde amnesia and memory consolidation: a neurobiological perspective. Curr Opin Neurobiol. 1995;5:169–177. [PubMed]
  • Tsvetkov E, Shin RM, Bolshakov VY. Glutamate uptake determines pathway specificity of long-term potentiation in the neural circuitry of fear conditioning. Neuron. 2004;41:139–151. [PubMed]
  • Ungless MA, Whistler JL, Malenka RC, Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature. 2001;411:583–587. [PubMed]
  • Usiello A, Baik JH, Rouge-Pont F, Picetti R, Dierich A, LeMeur M, Piazza PV, Borrelli E. Distinct functions of the two isoforms of dopamine D2 receptors. Nature. 2000;408:199–203. [PubMed]
  • Ventura R, Alcaro A, Cabib S, Conversi D, Mandolesi L, Puglisi-Allegra S. Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion. Neuropsychopharmacology. 2004;29:72–80. [PubMed]
  • Vickery RM, Morris SH, Bindman LJ. Metabotropic glutamate receptors are involved in long-term potentiation in isolated slices of rat medial frontal cortex. J Neurophysiol. 1997;78:3039–3046. [PubMed]
  • Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AF. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci. 2007;10:376–384. [PubMed]
  • Weiss S, Nosten-Bertrand M, McIntosh JM, Giros B, Martres MP. Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance. Neuropsychopharmacology. 2007;32:2465–2478. [PubMed]
  • Williams GV, Goldman-Rakic PS. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature. 1995;376:572–575. [PubMed]
  • Wood SC, Anagnostaras SG. Memory and psychostimulants: modulation of Pavlovian fear conditioning by amphetamine in C57BL/6 mice. Psychopharmacology (Berl) 2009;202:197–206. [PMC free article] [PubMed]
  • Wu K, Nigam SK, LeDoux M, Huang YY, Aoki C, Siekevitz P. Occurrence of the alpha subunits of G proteins in cerebral cortex synaptic membrane and postsynaptic density fractions: modulation of ADP-ribosylation by Ca2+/calmodulin. Proc Natl Acad Sci U S A. 1992;89:8686–8690. [PubMed]
  • Yasuda H, Barth AL, Stellwagen D, Malenka RC. A developmental switch in the signaling cascades for LTP induction. Nat Neurosci. 2003;6:15–16. [PubMed]
  • Zahrt J, Taylor JR, Mathew RG, Arnsten AF. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci. 1997;17:8528–8535. [PubMed]
  • Zhang J, Vinuela A, Neely MH, Hallett PJ, Grant SG, Miller GM, Isacson O, Caron MG, Yao WD. Inhibition of the dopamine D1 receptor signaling by PSD-95. J Biol Chem. 2007;282:15778–15789. [PMC free article] [PubMed]
  • Zhao MG, Toyoda H, Lee YS, Wu LJ, Ko SW, Zhang XH, Jia Y, Shum F, Xu H, Li BM, Kaang BK, Zhuo M. Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory. Neuron. 2005;47:859–872. [PubMed]
  • Zhuo M. Cortical excitation and chronic pain. Trends Neurosci. 2008;31:199–207. [PubMed]
  • Zucker RS. Short-term synaptic plasticity. Annu Rev Neurosci. 1989;12:13–31. [PubMed]